A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, June 2009

Altmetric Badge

Mentioned by

patent: 1 patent

Readers on

mendeley: 95 Mendeley

Summary Patents

So far, Altmetric has seen 1 patent that references this research output.

Selective efflux inhibitors and related pharmaceutical compositions and methods of…

Grant US-9056111-B1

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.